Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancers is a research paper published in Cytotherapy (2025). On theSindex it has a DataRank of 0.212. It has been cited 3 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
3.95 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Institutes of Health
Grant: U54CA268069
National Institutes of Health
Grant: R21AI163731
National Institutes of Health
Grant: R01AI146009
National Institutes of Health
Grant: P01CA254849
National Institutes of Health
Grant: R21CA237789
National Institutes of Health
Grant: P50CA136393
Children's Cancer Research Fund
Grant: U24OD026641
Children's Cancer Research Fund
Grant: U54CA232561
Children's Cancer Research Fund
Grant: R01AI161017
Children's Cancer Research Fund
Grant: P30CA077598
Intima Bioscience
Fanconi Cancer Foundation
Randy Shaver Cancer Research and Community Fund
FWCI
1.83
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals